AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Public Health, Vol. 88, Issue 4 571-575, Copyright © 1998 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Zoysa, I
Right arrow Articles by Bentley, M E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Zoysa, I
Right arrow Articles by Bentley, M E
Ethical challenges in efficacy trials of vaginal microbicides for HIV prevention.

I de Zoysa, C J Elias and M E Bentley

Department of International Health, Johns Hopkins University School of Public Hygiene, Baltimore, Md., USA.

This paper discusses some of the ethical challenges raised by advanced clinical trials designed to assess the safety and efficacy of vaginal microbicides in protecting women from HIV infection. The ethical principles that guide clinical research involving human subjects require that all participants in such trials be provided available measures known to reduce the risk of HIV infection. However, this will reduce the ability of the study to assess the protective effect of the test microbicide. In addition, providing extensive services to trial participants may be construed as an undue inducement if the study is being conducted among vulnerable groups such as sex workers or women from disadvantaged communities. Suggestions are provided to resolve this dilemma in the planning and implementation of HIV prevention services for trial participants.




This article has been cited by other articles:


Home page
Sex. Transm. Infect.Home page
A M Minnis and N S Padian
Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions
Sex Transm Inf, June 1, 2005; 81(3): 193 - 200.
[Abstract] [Full Text] [PDF]


Home page
J. Med. EthicsHome page
K Shapiro and S R Benatar
HIV prevention research and global inequality: steps towards improved standards of care
J. Med. Ethics, January 1, 2005; 31(1): 39 - 47.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. A. Brennan
Proposed Revisions to the Declaration of Helsinki -- Will They Weaken the Ethical Principles Underlying Human Research?
N. Engl. J. Med., August 12, 1999; 341(7): 527 - 531.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Public Health Association